The Board of Aster DM Healthcare Ltd has approved several significant initiatives. The company will acquire 1,90,46,028 equity shares in Quality Care India Limited (QCIL) from BCP Asia II TopCo IV Pte. Ltd and Centella Mauritius Holdings Limited, financing this acquisition through a preferential allotment of 1,86,07,969 equity shares at an issue price of INR 456.33 per share. This move aims to facilitate a merger with QCIL, enhancing operational synergies and expanding market reach.
Additionally, Aster plans to shift its registered office from Karnataka to Telangana, pending necessary approvals. Shareholder approval will be sought via postal ballot for both the issuance of securities and the relocation of the registered office.
The company is also pursuing a scheme of amalgamation with QCIL, aiming to leverage increased scale and financial resilience, while a shareholders’ agreement has been established to govern post-merger control dynamics. The overall developments suggest a positive outlook for Aster DM Healthcare, enhancing competitive positioning and future growth potential.